Vedic City woman alleges she and unborn child lead poisoned by Maharishi Ayurveda herbal preparation March 5, 2008
Posted by John in Crime/Courts, Medicine, Public Health.Tags: Brady & O’Shea, Cedar Rapids (Iowa), Centers for Disease Control, chelation therapy, Fairfield (Iowa), Frances Gaskell, Iowa Department of Public Health, lawsuits, lead poisoning, Maharishi Ayurveda, Maharishi Mahesh Yogi, University of Iowa Hospitals and Clinics, Vedic City (Iowa)
trackback
Plaintiff Frances Gaskell is being represented by Cedar Rapids legal firm Brady & O’Shea, P.C.
From United States District Court, Southern District of Iowa – Complaint and Jury Demand:
After Frances Gaskell began to take the Garbhapal Ras she began to feel lethargic and her hands and feet began going numb. She then began having severe back and abdominal pain. The pain was so severe that she was admitted for testing and treatment at the University of Iowa Hospitals and Clinics in February 2007. …
On April 16, 2007, blood test results showed that Frances Gaskell was severely lead poisoned and had a blood lead level of 102 mg/dl, over 20 times the level considered safe by the Centers for Disease Control. Because Frances’ level was so high, creating a serious risk to both her life and health, and the life and health of her unborn child, she was forced to undergo chelation therapy while pregnant despite the risks of the therapy to her unborn child, L.G..
After testing the different herbal preparations that Frances was taking, the Iowa Department of Public Health found that the Garbhapal Ras was made up of nearly 3% lead, a level far in excess of applicable safety standards. …
L.G. was born with a blood lead level of 60 mg/dl, 12 times the level considered safe by the Center for Disease. …
Full
Maybe the lead is meant to keep her from levitating away into the athmosphere.
The save blood lead level for a child is below 10 micrograms per deciliter, not 5 milligrams per decileter as stated here.
Recent, popular article about potential dangers of ayurvedic medicine.